VOGX

Healthcare Biotechnology

Vogenx, Inc.

$18.23

-1.83 -9.12% today

Price History

Not enough data

Key Stats

Market Cap

270.81M

Avg Volume

195,289

EPS

-$0.22

52W High

$38.41

52W Low

$12.95

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

P/B Ratio

-53.93

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Liquidity & Leverage

Current Ratio

0.44

Quick Ratio

0.06

Total Cash

193,017

Total Debt

867,700

About

Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.

vogenx.com